Canaccord Adams initiates coverage on Omeros Corporation (Nasdaq: OMER) with a Buy. Price target $13.

Canaccord analyst says, "PharmacoSurgery platform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE